SSY SunLink Health Systems, Inc: EV/Sales Multiple

Public company logo of SunLink Health Systems Inc. (SSY)

Stable bed occupancy rates and equipment upgrades support growth, validating the EV/Sales multiple. However, a moderate reliance on external IT outsourcing and the costs of implementing energy-efficient ESG standards are adjusting the trend. The current value of the parameter reaches , allowing for an objective valuation of SunLink Health Systems (SSY) relative to revenue, excluding debt obligations.

SunLink Health Systems, Inc. - SSY EV/Sales Multiple (period 07/04/2022 - 11/19/2026)

SunLink Health Systems - analytical breakdowns and key metrics (SSY)

- share price and consensus valuation forecast:
Initial company analysis:SunLink Health Systems - SSY
Core merchandise of SunLink Health Systems, Inc

The EV/Sales metric determines the enterprise value of a business, including net debt, per unit of revenue, allowing for an assessment of revenue generation efficiency regardless of financial leverage. The current EV to sales ratio stands at , reflecting the capitalization potential of SunLink Health Systems (SSY) through the optimization of rural clinics and the development of the pharmacy segment across US regions.

Direct competitors

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Company Value to Revenue|NIVF (NewGenIvf Group Limited) - Enterprise Value-to-Revenue Ratio|ATIP (ATI Physical Therapy Inc.) - EV/Sales Multiple|EV/Sales Multiple CareMax Inc.|Enterprise Value-to-Revenue Ratio Kindly MD Inc (KDLY)|Company Value to Revenue ModivCare Corp MODV|Novo Integrated - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple